ACTRN12616000024448进行中（未招募）4 期
A double blind randomised placebo controlled 2x2 factorial trial of the effect of Vitamin K and Colchicine on vascular calcification activity in patients with diabetes mellitus.
适应症
试验速览
- 阶段
- 4 期
- 状态
- 进行中（未招募）
- 入组人数
- 154
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 50 Years 至 80 Years（—）
- 性别
- All
入选标准
- •Type 1 or type 2 diabetes mellitus
排除标准
- •Prior or planned treated with coronary bypass surgery or percutaneous coronary intervention.
- •Symptomatic coronary disease
- •Advanced renal disease
- •Known intolerance to Vit K or colchicine
- •Existing treatment with warfarin or another Vit K
- •Active cancer
- •Arrhythmia that precludes ECG gated PET/CT
- •Hyperthyroidism
- •Current treatment for Paget' s disease,
- •Chronic inflammatory conditions requiring chronic intake of antibiotics,steroids or immunosupressant.
- •Chronic diarrhoea
研究者
相似试验
尚未招募
不适用
The Indacaterol in Lymphangioleiomymotosis (LAM) TrialymphangioleiomyomatosisRespiratory - Other respiratory disorders / diseasesLymphangioleiomyomatosisACTRN12613001251718Deborah H Yates15
进行中（未招募）
1 期
se of low-dose zolpidem in Parkinson's.Parkinson's DiseaseEUCTR2017-004297-34-GBAston University28
招募中
1 期
A double blind randomised placebo-controlled intervention trial to determine the efficacy of the probiotic VSL #3 in reducing the incidence and or frequency of diarrhoea in enterally-fed critically ill patients.Diarrhoeal illness and infection in critically ill patientsInfection - Studies of infection and infectious agentsACTRN12605000167662Department of Health and Human Services (Tasmanian Government)100
已完成
不适用
A 2 x 2 randomised, double blind, placebo controlled trial of pentoxifylline (trental) +/- high dose vitamins for radiation induced bowel toxicity: the ROBOTS 2 trialISRCTN33398289Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
进行中（未招募）
1 期
A randomised controlled trial to evaluate the feasibility of administering a drug called desmopressin to Intensive Care patients prior to procedures or radiological interventions, for prophylaxis against bleeding.EUCTR2016-001126-33-GBHS Blood and Transplant40